ESC CVD Risk Calculation
ESC CVD Risk Calculation Summary
ESC CVD Risk Calculation is a Android app in the Medical category, developed by European Society of Cardiology. First released 5 years ago(Apr 2020), the app has accumulated 144.3K+ total installs and 504 ratings with a 5.00★ (excellent) average rating.
Recent activity: 649 installs this week (3.6K over 4 weeks) showing below average growth , and 2 new ratings this week (9 over 4 weeks) with slowing momentum. View trends →
Data tracking: SDKs and third-party integrations were last analyzed on Dec 18, 2025. The app's network data flows (API traffic to/from the app and its SDKs) were last crawled on Sep 15, 2025.
Store info: Last updated on Google Play on May 16, 2025 (version 37).
ESC CVD Risk Calculation was last scanned for SDKs 2025-12-18. Below is the overview of third party companies detected in the app. The full list of raw SDKs, app permissions and unknown SDKs is available here.
Google
Kotlin
Square
Firebase5★
Ratings: 504
Screenshots
App Description
Individual cardiovascular risk assessment for healthcare professionals
The ESC CVD Risk Calculation App is designed for healthcare professionals. It provides calculators assessing individual cardiovascular risk. It includes calculators for primary and secondary prevention in various populations:
SCORE2
SCORE2-OP
SCORE2-Diabetes
ASCVD
SMART
SMART-REACH*
DIAL*
LIFE-CVD*
* Available online on U-Prevent (Internet connection required)
The ESC CVD Risk Calculation App is available in English. It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk. Of note, patient data are not stored in the App.
This application is only for informative use and is not intended to provide therapeutic support or diagnosis assistance.
This Application is powered by the European Society of Cardiology (ESC), based upon the source codes of the U-Prevent webtool, a concept developed by University Medical Center Utrecht, redesigned and owned by ORTEC.
The SCORE2, SCORE2-OP and SCORE2-Diabetes calculators were developed in collaboration with the ESC Cardiovascular Risk Collaboration unit.
The Application has recently been updated in the framework of the EAPC IMPLEMENT Programme (2023) which was supported by Novo Nordisk in the form of an educational grant. The sponsor did not have any involvement or influence on the features nor on the scientific contents within the Application.